Deschner E E, Long F C, Hakissian M
Laboratory of Digestive Tract Carcinogenesis, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Cancer. 1988 Feb 1;61(3):478-82. doi: 10.1002/1097-0142(19880201)61:3<478::aid-cncr2820610312>3.0.co;2-a.
Hybrid crosses were performed between SWR/J, a strain highly sensitive to 1,2-dimethylhydrazine (DMH), and AKR/J, a strain highly resistant to the carcinogen. F1 and F2 and reciprocal backcrosses were tested to determine if proliferative characteristics such as high activity, wide compartment (PC), and a large S-phase population in the middle third of crypts were linked to susceptibility and inherited as a dominant autosomal trait as was reported for DMH tumor response. A blend of resistant and sensitive tumor and proliferative characteristics was observed in the F1 and F2 crosses. A tumor incidence of 43.7% in the F1 and 52% in the F2 was obtained rather than the respective 100% and 75% expected frequencies. One week after the sixth injection of DMH, the incidence of focal areas of atypism (FAA) in the backcross to resistance (BCR) and the backcross to sensitivity (BCS) was the same (4.1 per FAA-bearing animal). This suggested that the response to the carcinogen was similar in both groups up to this point. Yet 20 weeks later, the BCR had a 7.3% tumor incidence, far lower than the 50% incidence expected. The BCS had an incidence of 98.6%, not unlike SWR frequencies and close to the expected 100% tumor incidence. Proliferative characteristics in the backcrosses, however, did not revert to parental levels. Instead, the labeling index (LI) or percentage of S-phase cells to total cells scored was significantly higher in the BCR than in the BCS (10.2% +/- 3.2% versus 8.1% +/- 2.2%, P less than 0.02). This study has shown that in crosses between these two strains (SWR/J and AKR/J), susceptibility to DMH-induced tumor is not inherited as a dominant trait. Neither are the proliferative characteristics of the colonic mucosa inherited in a simple Mendelian manner nor are the kinetic properties of the epithelial cells linked to DMH tumor susceptibility. It is suggested that the parental AKR/J strain may contribute a protective or resistant factor, that is, a repressor gene, which impedes the progression of carcinogen-induced foci of dysplasia to colonic neoplasia.
将对1,2 - 二甲基肼(DMH)高度敏感的SWR/J品系与对该致癌物高度抗性的AKR/J品系进行杂交。对F1、F2及正反交回交后代进行检测,以确定诸如高活性、宽间隔(PC)以及隐窝中三分之一处大的S期群体等增殖特征是否与易感性相关联,并如DMH肿瘤反应报道的那样作为显性常染色体性状遗传。在F1和F2杂交后代中观察到抗性和敏感肿瘤及增殖特征的混合情况。F1的肿瘤发生率为43.7%,F2为52%,而非预期的分别为100%和75%。在第六次注射DMH一周后,回交至抗性(BCR)和回交至敏感(BCS)组中不典型病灶区域(FAA)的发生率相同(每只携带FAA的动物为4.1个)。这表明截至此时两组对致癌物的反应相似。然而20周后,BCR的肿瘤发生率为7.3%,远低于预期的50%发生率。BCS的发生率为98.6%,与SWR的频率相似且接近预期的100%肿瘤发生率。然而,回交后代中的增殖特征并未恢复到亲本水平。相反,BCR中标记指数(LI)或S期细胞占总计数细胞的百分比显著高于BCS(10.2%±3.2%对8.1%±2.2%,P<0.02)。本研究表明,在这两个品系(SWR/J和AKR/J)的杂交中,对DMH诱导肿瘤的易感性并非作为显性性状遗传。结肠黏膜的增殖特征既不是以简单孟德尔方式遗传,上皮细胞的动力学特性也与DMH肿瘤易感性无关。有人提出亲本AKR/J品系可能贡献了一种保护或抗性因子,即一个阻遏基因,它阻碍致癌物诱导的发育异常病灶向结肠肿瘤的进展。